2 completed, 1 terminated. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow ZymoGenetics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis Atacicept, Mycophenolate mofetil, Placebo - Lupus Nephritis | Phase 2 / Phase 3 | Terminated | EMD Serono | 6 | 2007-12-01 | 2016-03-23 |
| Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis rThrombin - Spinal Surgery, Vascular Surgery | Phase 3 | Completed | ZymoGenetics | 234 | 2007-06-01 | 2012-01-13 |
| Study of Recombinant Human Thrombin for Bleeding During Surgery rThrombin, bovine thrombin - Surgical Hemostasis | Phase 3 | Completed | ZymoGenetics | 401 | 2005-10-01 | 2009-03-09 |
Lupus Nephritis (1) · Nephritis (1)
recombinant human thrombin (2) · Adrenal Cortex Hormones (1) · Mycophenolic Acid (1) · TACI receptor-IgG Fc fragment fusion protein (1) · Thrombin (1)
United States (3) · Czechia (1) · Malaysia (1) · Singapore (1) · Taiwan (1)
Allan Alexander, MD, CPI (1) · Fred Weaver, MD (1) · Kenneth Renkens, MD (1) · Thomas C Reynolds, MD, PhD (1) · William Chapman, MD (1)
PMID 17660072, PMID 18440754, PMID 19651065, PMID 20980172, PMID 22325903